Clinical Trials Directory

Trials / Unknown

UnknownNCT02848846

NEurocontrolled BIdirectional Artificial Upper Limb and Hand prosthesiS

Status
Unknown
Phase
N/A
Study type
Interventional
Enrollment
2 (estimated)
Sponsor
Paolo Maria Rossini · Academic / Other
Sex
All
Age
18 Years
Healthy volunteers
Not accepted

Summary

The NEBIAS ("NEurocontrolled BIdirectional Artificial upper limb and hand prosthesiS") proposal aims at developing and clinically evaluating (in selected amputees) a neuro-controlled upper limb prosthesis intuitively controlled and felt by the amputee as the natural one. This will be possible by means of a novel neural interface able to provide a stable and very selective connection with the nervous system. This goal will be achieved by combining microtechnology and material science and will allow, on one side, recording of the motor-related signals governing the actions of the amputated hand/arm for the motion control of a mechanical prosthesis, and on the other providing sensory feedback from tactile and kinesthetic sensors through neuromorphic stimulation of the adequate afferent pathway within the residual limb. The NEBIAS proposal is also aimed at finding out the 'language' intrinsically linking central nervous system with peripheral nerve signals in order to govern simple and complex hand/fingers movements. To reach this goal, a variety of techniques exploring brain and nerve functions will be assembled and integrated; this includes the analysis of electromagnetic brain and nerve signals, as well as of movement-related changes in brain's blood flow/metabolism.

Conditions

Interventions

TypeNameDescription
DEVICERobotic HandThe patients will use the robotic hand for a period of one year that will be divided in 3 different phases. The first phase is the intensive phase where the patient will use the robotic hand from Monday to Friday all days. This phase will last 6 weeks. The second phase is the semi-intensive where the patient will use the robotic hand only two days per week. This phase will last 6 weeks. The third phase is the monitoring where the patient will use the robotic hand only one day per week until the end of the trial. During this phases the patient will perform different task requiring the use of the robotic hand.

Timeline

Start date
2016-06-01
Primary completion
2017-06-01
Completion
2018-12-01
First posted
2016-07-29
Last updated
2016-07-29

Locations

1 site across 1 country: Italy

Source: ClinicalTrials.gov record NCT02848846. Inclusion in this directory is not an endorsement.